Takeda Pharmaceutical (TAK) Other Non-Current Liabilities: 2018-2025

  • Takeda Pharmaceutical's Other Non-Current Liabilities fell 0.94% to $541.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $541.0 million, marking a year-over-year decrease of 0.94%. This contributed to the annual value of $541.9 million for FY2025, which is 3.45% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Other Non-Current Liabilities stood at $541.0 million for Q1 2025, which was down 0.94% from $546.2 million recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Other Non-Current Liabilities high stood at $546.2 million for Q1 2024, and its period low was $366.1 million during Q1 2021.
  • Over the past 3 years, Takeda Pharmaceutical's median Other Non-Current Liabilities value was $541.0 million (recorded in 2025), while the average stood at $503.4 million.
  • Per our database at Business Quant, Takeda Pharmaceutical's Other Non-Current Liabilities dropped by 5.80% in 2023 and then increased by 29.08% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Other Non-Current Liabilities (Quarterly) stood at $366.1 million in 2021, then grew by 22.70% to $449.2 million in 2022, then fell by 5.80% to $423.1 million in 2023, then grew by 29.08% to $546.2 million in 2024, then fell by 0.94% to $541.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $541.0 million for Q1 2025, versus $546.2 million for Q1 2024 and $423.1 million for Q1 2023.